Literature DB >> 7846030

Differentiation and cancer: the conditional autonomy of phenotype.

R G Lynch1.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7846030      PMCID: PMC42676          DOI: 10.1073/pnas.92.3.647

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Clinicopathologic conference: Multiple malignancies: chronic lymphocytic leukemia, malignant melanoma, multiple myeloma and acute myelomonocytic leukemia.

Authors: 
Journal:  Am J Med       Date:  1975-03       Impact factor: 4.965

2.  Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation.

Authors:  J W Rohrer; K Vasa; R G Lynch
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Antigen-specific regulation of myeloma cell differentiation in vivo by carrier-specific T cell factors and macrophages.

Authors:  J W Rohrer; R G Lynch
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  Suppressor T cell action inhibits the expression of an excluded immunoglobulin gene.

Authors:  T G Parslow; G L Milburn; R G Lynch; D K Granner
Journal:  Science       Date:  1983-06-24       Impact factor: 47.728

5.  Idiotype-specific suppression of MOPC-315 IgA secretion in vivo: reversible blockade of secretory myeloma cells by soluble mediators.

Authors:  J W Rohrer; B Odermatt; R G Lynch
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

6.  Immunoregulation of localized and disseminated murine myeloma: antigen-specific regulation of MOPC-315 stem cell proliferation and secretory cell differentiation.

Authors:  J W Rohrer; R G Lynch
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

7.  Cytogenetic evidence for the clonal nature of Richter's syndrome.

Authors:  P Nowell; J Finan; D Glover; D Guerry
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

8.  Richter's syndrome in chronic lymphocytic leukemia.

Authors:  K Foucar; R E Rydell
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860

9.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC-315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cells.

Authors:  G L Milburn; R G Lynch
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  4 in total

1.  Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.

Authors:  M J Hendrix; E A Seftor; R E Seftor; K T Trevor
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 2.  Role of intermediate filaments in migration, invasion and metastasis.

Authors:  M J Hendrix; E A Seftor; Y W Chu; K T Trevor; R E Seftor
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 3.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

4.  Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.

Authors:  Kathy Qi Cai; Corrado Caslini; Callinice D Capo-chichi; Carolyn Slater; Elizabeth R Smith; Hong Wu; Andres J Klein-Szanto; Andrew K Godwin; Xiang-Xi Xu
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.